Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept Study

NCT03123913 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT03123913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept Study
Lead sponsor
University of Rochester
Phase
Phase 1
Overall status
Completed
Start date
December 18, 2017
Completion date
March 28, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facioscapulohumeral muscular dystrophy